HLB Co., Ltd.
028300
Classement en actions
#3922
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Prix de l'action
$31.12
Capitalisation boursière
$4.14B
Changement (1 jour)
6.26%
Changement (1 an)
0.78%
Pays
KR
Échange HLB Co., Ltd. (028300)
Catégorie
Healthcare
Revenus pour HLB Co., Ltd. (028300)
Revenus en Jun 2026 TTM : $67.40M
Selon les derniers rapports financiers de HLB Co., Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de $67.40M. En 2023, l'entreprise a réalisé un chiffre d'affaires de $33.14M une diminution par rapport à le chiffre d'affaires de l'année 2022, qui était de $142.41M. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour HLB Co., Ltd. de 2012 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $67.40M | 45.45% |
| 2024 | $46.34M | 39.83% |
| 2023 | $33.14M | -76.73% |
| 2022 | $142.41M | 142.47% |
| 2021 | $58.73M | 13.50% |
| 2020 | $51.75M | 55.52% |
| 2019 | $33.27M | 2.38% |
| 2018 | $32.50M | 50.54% |
| 2017 | $21.59M | -13.64% |
| 2016 | $25.00M | -23.62% |
| 2015 | $32.73M | -3.69% |
| 2014 | $33.98M | 71.94% |
| 2013 | $19.76M | -59.26% |
| 2012 | $48.51M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $12.62B | 18,631.01% |
US
|
|
| $2.23B | 3,205.74% |
US
|
|
| $15.74B | 23,260.28% |
AU
|
|
| $6.02B | 8,833.94% |
NL
|
|
| - | - |
CH
|
